{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:31:26Z","timestamp":1785893486266,"version":"3.56.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this secondary analysis of Hispanic adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) treated on Cancer and Leukemia Group B (CALGB) 10403, we evaluated outcomes and geographic enrollment patterns relative to US population data. We used demographic, clinical, and survival data on AYAs enrolled on CALGB 10403 (N = 295, 2007-2012). Surveillance, Epidemiology, and End Results registries provided overall survival (OS) for US AYA ALL by ethnicity\/race. North American Association of Cancer Registries provided AYA ALL incidence overall and proportion among Hispanics by US state. Of AYAs enrolled on CALGB 10403, 263 (89%) reported ethnicity\/race: 45 (17%) Hispanic, 172 (65%) non-Hispanic White (NHW), 25 (10%) non-Hispanic Black (NHB), and 21 (8%) other. Compared with NHWs, Hispanic and NHB patients had lower household income, and Hispanic patients were more likely to harbor high-risk CRLF2 aberrations. Relative to US estimates, where Hispanic patients represented 46% of newly diagnosed AYA ALL patients and experienced inferior OS compared with NHW (P &amp;lt; .001), Hispanic AYAs on CALGB 10403 did as well as NHW patients (3 year OS, 75% vs 74%; P = NS). Hispanic patients also had higher rates of protocol completion (P = .05). Enrollments on CALGB 10403 differed relative to the distribution of Hispanic AYA ALL in the United States: enrollment was highest in the Midwest; t and only 15% of enrollees were from states with a high proportion of Hispanic AYA ALL patients. In summary, Hispanic patients treated on CALGB 10403 did as well as NHWs and better than population estimates. Geographical misalignment between trial sites and disease epidemiology may partially explain the lower-than-expected enrollment of Hispanic AYA ALL patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007197","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T15:37:24Z","timestamp":1657899444000},"page":"4085-4092","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-6136","authenticated-orcid":false,"given":"Lori","family":"Muffly","sequence":"first","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-9664","authenticated-orcid":false,"given":"Jun","family":"Yin","sequence":"additional","affiliation":[{"name":"2Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawyer","family":"Jacobson","sequence":"additional","affiliation":[{"name":"2Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wall","sequence":"additional","affiliation":[{"name":"2Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Quiroz","sequence":"additional","affiliation":[{"name":"3Scripps MD Anderson Cancer Center, San Diego, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-5902","authenticated-orcid":false,"given":"Anjali S.","family":"Advani","sequence":"additional","affiliation":[{"name":"4Taussig Cancer Institute\/Leukemia Program, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina M.","family":"Luger","sequence":"additional","affiliation":[{"name":"5Division of Hematology Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Tallman","sequence":"additional","affiliation":[{"name":"6Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark R.","family":"Litzow","sequence":"additional","affiliation":[{"name":"7Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Foster","sequence":"additional","affiliation":[{"name":"8Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1093-2189","authenticated-orcid":false,"given":"Harry P.","family":"Erba","sequence":"additional","affiliation":[{"name":"9Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"10Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-3203","authenticated-orcid":false,"given":"Richard A.","family":"Larson","sequence":"additional","affiliation":[{"name":"11Department of Medicine, Section of Hematology\/Oncology, University of Chicago, Chicago, IL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa H.M.","family":"Keegan","sequence":"additional","affiliation":[{"name":"12Division of Hematology\/Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[{"name":"11Department of Medicine, Section of Hematology\/Oncology, University of Chicago, Chicago, IL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"2022071515371512200_B1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.blre.2018.08.002","article-title":"The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implications","volume":"33","author":"Quiroz","year":"2019","journal-title":"Blood Rev."},{"issue":"4","key":"2022071515371512200_B2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwaa215","article-title":"Trends in acute lymphoblastic leukemia incidence in the United States by race\/ethnicity from 2000 to 2016","volume":"190","author":"Feng","year":"2021","journal-title":"Am J Epidemiol."},{"issue":"19","key":"2022071515371512200_B3","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/cncr.33678","article-title":"Racial and ethnic disparities in pediatric cancer incidence among children and young adults in the United States by single year of age","volume":"127","author":"Marcotte","year":"2021","journal-title":"Cancer."},{"issue":"5","key":"2022071515371512200_B4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10552-012-9943-8","article-title":"Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008","volume":"23","author":"Goggins","year":"2012","journal-title":"Cancer Causes Control."},{"issue":"20","key":"2022071515371512200_B5","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/cncr.31560","article-title":"Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?","volume":"124","author":"Kehm","year":"2018","journal-title":"Cancer."},{"issue":"8","key":"2022071515371512200_B6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/jnci\/djab006","article-title":"Disparities in cancer survival among adolescents and young adults: a population-based study of 88\u2009000 patients","volume":"113","author":"Murphy","year":"2021","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"2022071515371512200_B7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.26156","article-title":"Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017","volume":"96","author":"Sasaki","year":"2021","journal-title":"Am J Hematol."},{"issue":"26","key":"2022071515371512200_B8","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood."},{"issue":"5","key":"2022071515371512200_B9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood."},{"issue":"12","key":"2022071515371512200_B10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ng.2803","article-title":"Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse","volume":"45","author":"Perez-Andreu","year":"2013","journal-title":"Nat Genet."},{"issue":"3","key":"2022071515371512200_B11","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1002\/ajh.26065","article-title":"GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis","volume":"96","author":"Koller","year":"2021","journal-title":"Am J Hematol."},{"issue":"3","key":"2022071515371512200_B12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/annonc\/mdu572","article-title":"Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis","volume":"26","author":"Petridou","year":"2015","journal-title":"Ann Oncol."},{"issue":"20","key":"2022071515371512200_B13","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1002\/cncr.33760","article-title":"Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1","volume":"127","author":"Hoppmann","year":"2021","journal-title":"Cancer."},{"issue":"2","key":"2022071515371512200_B14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.2021011106","article-title":"Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia","volume":"138","author":"Mittelman","year":"2021","journal-title":"Blood."},{"issue":"5","key":"2022071515371512200_B15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther."},{"issue":"21","key":"2022071515371512200_B16","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1182\/bloodadvances.2021005148","article-title":"Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials","volume":"5","author":"Hantel","year":"2021","journal-title":"Blood Adv."},{"issue":"14","key":"2022071515371512200_B17","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood."},{"key":"2022071515371512200_B18","author":"National Cancer Institute"},{"issue":"12","key":"2022071515371512200_B19","first-page":"1117","article-title":"The surveillance, epidemiology, and end results program: a national resource","volume":"8","author":"Hankey","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2022071515371512200_B20","author":"North American Association of Central Cancer Registries"},{"key":"2022071515371512200_B21","author":"World Health Organization"},{"issue":"23","key":"2022071515371512200_B22","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1002\/cncr.33853","article-title":"Disparities in phase 1 cancer clinical trial enrollment","volume":"127","author":"Perni","year":"2021","journal-title":"Cancer."},{"issue":"1","key":"2022071515371512200_B23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/jayao.2021.0008","article-title":"Health insurance payer type and ethnicity are associated with cancer clinical trial enrollment among adolescents and young adults","volume":"11","author":"Sullenger","year":"2022","journal-title":"J Adolesc Young Adult Oncol."},{"issue":"3","key":"2022071515371512200_B24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.46883\/ONC.2021.3503.0107","article-title":"Minority enrollment to clinical trials: road to increased access","volume":"35","author":"Vose","year":"2021","journal-title":"Oncology (Williston Park)."},{"key":"2022071515371512200_B25","author":"U.S. Food and Drug Administration","year":"2021"},{"issue":"11","key":"2022071515371512200_B26","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1080\/10428194.2020.1779260","article-title":"Acute lymphoblastic leukemia mortality in Hispanic Americans","volume":"61","author":"Shoag","year":"2020","journal-title":"Leuk Lymphoma."},{"issue":"5","key":"2022071515371512200_B27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MPH.0000000000000591","article-title":"Effects of race\/ethnicity and socioeconomic status on outcome in childhood acute lymphoblastic leukemia","volume":"38","author":"Acharya","year":"2016","journal-title":"J Pediatr Hematol Oncol."},{"key":"2022071515371512200_B28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2021-147386","article-title":"Racial, ethnic and socioeconomic factors result in disparities in outcome among children with acute lymphoblastic leukemia not fully attenuated by disease prognosticators: a Children\u2019s Oncology Group study","volume":"138","author":"Gupta","year":"2021","journal-title":"Blood."},{"issue":"15","key":"2022071515371512200_B29","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood-2014-01-552166","article-title":"6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"124","author":"Bhatia","year":"2014","journal-title":"Blood."},{"issue":"12","key":"2022071515371512200_B30","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/djz043","article-title":"Genome-wide association study of susceptibility loci for T-cell acute lymphoblastic leukemia in children","volume":"111","author":"Qian","year":"2019","journal-title":"J Natl Cancer Inst."},{"issue":"28","key":"2022071515371512200_B31","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.20.00256","article-title":"Children\u2019s Oncology Group AALL0434: a phase III randomized clinical trial testing nelarabine in newly diagnosed T-cell acute lymphoblastic leukemia","volume":"38","author":"Dunsmore","year":"2020","journal-title":"J Clin Oncol."},{"key":"2022071515371512200_B32","author":"American Society of Clinical Oncology, Association of Community Cancer Centers"},{"key":"2022071515371512200_B33","author":"National Institutes of Health"},{"key":"2022071515371512200_B34","author":"U.S. Food and Drug Administration"},{"issue":"22","key":"2022071515371512200_B35","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA."},{"issue":"2","key":"2022071515371512200_B36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.23157","article-title":"Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review","volume":"112","author":"Ford","year":"2008","journal-title":"Cancer."},{"key":"2022071515371512200_B37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cct.2014.11.013","article-title":"Motivators and barriers to Latinas\u2019 participation in clinical trials: the role of contextual factors","volume":"40","author":"London","year":"2015","journal-title":"Contemp Clin Trials."},{"issue":"10","key":"2022071515371512200_B38","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/ijerph15102091","article-title":"Cancer health literacy and willingness to participate in cancer research and donate bio-specimens","volume":"15","author":"Echeverri","year":"2018","journal-title":"Int J Environ Res Public Health."},{"issue":"2","key":"2022071515371512200_B39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cct.2014.08.004","article-title":"Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review","volume":"39","author":"Heller","year":"2014","journal-title":"Contemp Clin Trials."},{"issue":"2","key":"2022071515371512200_B40","doi-asserted-by":"crossref","first-page":"e55689","DOI":"10.1371\/journal.pone.0055689","article-title":"Heuristic algorithms for assigning Hispanic ethnicity","volume":"8","author":"Boscoe","year":"2013","journal-title":"PLoS One."},{"issue":"3","key":"2022071515371512200_B41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1047-2797(96)00154-8","article-title":"Predictors of misclassification of Hispanic ethnicity in a population-based cancer registry","volume":"7","author":"Swallen","year":"1997","journal-title":"Ann Epidemiol."},{"issue":"14","key":"2022071515371512200_B42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.18.01074","article-title":"Comparison of population-based observational studies with randomized trials in oncology","volume":"37","author":"Soni","year":"2019","journal-title":"J Clin Oncol."},{"issue":"16","key":"2022071515371512200_B43","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2017.72.6414","article-title":"Untapped potential of observational research to inform clinical decision making: American Society of Clinical Oncology research statement","volume":"35","author":"Visvanathan","year":"2017","journal-title":"J Clin Oncol."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/14\/4085\/1906915\/advancesadv2022007197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/14\/4085\/1906915\/advancesadv2022007197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T15:37:57Z","timestamp":1657899477000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/14\/4085\/484493\/Disparities-in-trial-enrollment-and-outcomes-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":43,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,7,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007197","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}